Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • EMeyer
    Junior Member
    • Jul 2008
    • 7

    #1

    DESeq: GLMs for RNA-Seq with interaction terms

    I have a reasonably large RNA-Seq dataset for a non-model plant, and want to fit a GLM with interaction terms:
    expression ~ treatment + time + treatment:time

    In theory, I should be able to test the significance of each term by comparing a reduced model (dropping that term) with the full model above.

    It seems DESeq can handle this for main effect terms: it produces a vector of p-values with a reasonable distribution. See this example, using data from the pasilla package:
    data(pasillaGenes)
    design <- pData(pasillaGenes)[, c("condition", "type")]
    fullCountsTable <- counts(pasillaGenes)
    cdsFull <- newCountDataSet(fullCountsTable[1:1000,], design)
    cdsFull <- estimateSizeFactors(cdsFull)
    cdsFull <- estimateDispersions(cdsFull, method="pooled")
    fit1 <- fitNbinomGLMs(cdsFull, count ~ type + condition)
    fit0 <- fitNbinomGLMs(cdsFull, count ~ type)
    pvalsGLM <- nbinomGLMTest(fit1, fit0)


    However, when I try this with an interaction term included it gives clearly wrong results: every p value is either 0 or 1.
    fit1 <- fitNbinomGLMs(cdsFull, count ~ type + condition + type:condition)
    fit0 <- fitNbinomGLMs(cdsFull, count ~ type + type:condition)
    pvalsGLM <- nbinomGLMTest(fit1, fit0)

    So my questions:
    (a) Is this even possible in DESeq?
    (b) If so, can anyone spot the error in how I coded this?

    Thanks for any advice!
  • Simon Anders
    Senior Member
    • Feb 2010
    • 995

    #2
    Hi

    you test for a rather odd contrast:
    Code:
    fit1 <- fitNbinomGLMs(cdsFull, count ~ type + condition + type:condition)
    fit0 <- fitNbinomGLMs(cdsFull, count ~ type + type:condition)
    The standard ANOVA or ANODEV approach is to test first for main effects without any interaction terms present in the fit, and then for the interaction, with all main effect present in both fits, i.e.,

    Code:
    fit1 <- fitNbinomGLMs(cdsFull, count ~ type + condition + type:condition)
    fit0 <- fitNbinomGLMs(cdsFull, count ~ type + condition)
    For the pasilla data, this shouldn't give many hits, though. (If there were interactions, this would be rather worrying.)

    Comment

    • raphael123
      Member
      • Dec 2013
      • 37

      #3
      Hi Simon !
      Usually each coeficient in a GLM is associated with a p value, do you know how to get these p value from the GLM of DEseq ?

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 07:41 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...